Latest issue of Haemostaseolgy

| home

The free access does not apply to institutional or commercial use.
Information: claudia.boehm@schattauer.de

Current Issue

Issues of 2012 (Vol. 32): Issue 2 2012 (87-170)

Journal:	Hämostaseologie
ISSN:	0720-9355

Issue

10 articles

	1.	Das Gendiagnostikgesetz Statt Aufregung und Panik lieber eine sinnvolle Strategie
		C. Bode, U. Walter, A. Tiede, S. Herterich Hämostaseologie 2012 32 2: 91-93
		[Summary] [Free download]

	2.	Tumor und Thrombose
		C. Ay, I. Pabinger Hämostaseologie 2012 32 2: 94-94
		[Summary] [Free download]

	3.	Crosstalk between cancer and haemostasis Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor
		F. Langer (1), C. Bokemeyer (1) (1) Hubertus Wald Tumorzentrum – Universitäres Cancer Center Hamburg, Universitätsklinikum Hamburg-Eppendorf Hämostaseologie 2012 32 2: 95-104 http://dx.doi.org/10.5482/ha-1160
		[Summary] [Free download]

	4.	Angiogenesis in cancer Basic mechanisms and therapeutic advances
		G. W. Prager (1), M. Poettler (1) (1) Comprehensive Cancer Center Vienna, Department of Medicine I, Medical University of Vienna, Austria Hämostaseologie 2012 32 2: 105-114 http://dx.doi.org/10.5482/ha-1163
		[Summary] [Free download]

	5.	Epidemiology, risk and outcomes of venous thromboembolism in cancer
		A. Falanga (1), L. Russo (1) (1) Division of Immunohematology and Transfusion Medicine, Dept. Oncology-Hematology, Ospedali Riuniti, Bergamo, Italy Hämostaseologie 2012 32 2: 115-125 http://dx.doi.org/10.5482/ha-1170
		[Summary] [Free download]

	6.	Clinical significance of circulating microparticles for venous thromboembolism in cancer patients
		J. Thaler (1), C. Ay (2), I. Pabinger (2) (1) Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna – Vienna General Hospital, Vienna, Austria; (2) Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria Hämostaseologie 2012 32 2: 127-131 http://dx.doi.org/10.5482/ha-1164
		[Summary] [Free download]

	7.	Risk of venous thromboembolism and primary prophylaxis in cancer Should all patients receive thromboprophylaxis?
		I. Pabinger (1), C. Ay (1) (1) Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria Hämostaseologie 2012 32 2: 132-137 http://dx.doi.org/10.5482/ha-1173
		[Summary] [Free download]

	8.	Treatment and secondary prevention of venous thromboembolism in cancer patients Current strategies and new therapeutic options
		C. Ay (1), I. Pabinger (1) (1) Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria Hämostaseologie 2012 32 2: 139-144 http://dx.doi.org/10.5482/ha-1168
		[Summary] [Free download]

	9.	Zertifizierte Fortbildung: Behandlung und sekundäre Prävention venöser Thromboembolien bei Krebspatienten
		Hämostaseologie 2012 32 2: 145-145
		[Summary] [Free download]

	10.	Thrombophilia screening in young patients with cryptogenic stroke Prevalence of gene polymorphisms compared to healthy blood donors and impact on secondary stroke prevention
		K. G. Haeusler (1, 2), J. Herm (2), B. Hoppe (3), R. Kasabov (1), U. Malzahn (2), M. Endres (1, 2, 4), J. Koscielny (5), G. J. Jungehulsing (1, 2) (1) Department of Neurology, Charité – Universitätsmedizin Berlin, Germany; (2) Center for Stroke Research, Charité – Universitätsmedizin Berlin, Germany; (3) Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité – Universitätsmedizin Berlin, Germany; (4) Exzellenzcluster NeuroCure, Charité – Universitätsmedizin Berlin, Germany; (5) Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Germany Hämostaseologie 2012 32 2: 147-152 http://dx.doi.org/10.5482/ha-1175
		[Summary] [Free download]